
### [NCIT:C8693](http://purl.obolibrary.org/obo/NCIT_C8693)
**Label:** Stage IV Mature T- and NK-Cell Lymphoma

**Subclasses:** [NCIT:C7802](http://purl.obolibrary.org/obo/NCIT_C7802) (Stage IV Mycosis Fungoides), [NCIT:C8679](http://purl.obolibrary.org/obo/NCIT_C8679) (Stage IV Angioimmunoblastic T-cell Lymphoma), [NCIT:C88160](http://purl.obolibrary.org/obo/NCIT_C88160) (Stage IV Mycosis Fungoides and Sezary Syndrome), [NCIT:C8685](http://purl.obolibrary.org/obo/NCIT_C8685) (Stage IV Enteropathy-Associated T-Cell Lymphoma), [NCIT:C8675](http://purl.obolibrary.org/obo/NCIT_C8675) (Stage IV Nasal Type NK/T-Cell Lymphoma), [NCIT:C115032](http://purl.obolibrary.org/obo/NCIT_C115032) (Stage IV Childhood Anaplastic Large Cell Lymphoma), [NCIT:C8662](http://purl.obolibrary.org/obo/NCIT_C8662) (Stage IV Anaplastic Large Cell Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 53.30%
- [NCIT:C27971](http://purl.obolibrary.org/obo/NCIT_C27971) (Stage IV) 52.94%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40255](http://purl.obolibrary.org/obo/NCIT_C40255) (Vaginal Mullerian Papilloma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40252](http://purl.obolibrary.org/obo/NCIT_C40252) (Vaginal Mucinous Adenocarcinoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40251](http://purl.obolibrary.org/obo/NCIT_C40251) (Vaginal Endometrioid Adenocarcinoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40248](http://purl.obolibrary.org/obo/NCIT_C40248) (Vaginal Warty Carcinoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40245](http://purl.obolibrary.org/obo/NCIT_C40245) (Vaginal Basaloid Carcinoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40243](http://purl.obolibrary.org/obo/NCIT_C40243) (Vaginal Keratinizing Squamous Cell Carcinoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40239](http://purl.obolibrary.org/obo/NCIT_C40239) (Cervical Melanoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40236](http://purl.obolibrary.org/obo/NCIT_C40236) (Cervical Wilms Tumor))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40231](http://purl.obolibrary.org/obo/NCIT_C40231) (Cervical Adenomyoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40230](http://purl.obolibrary.org/obo/NCIT_C40230) (Cervical Adenofibroma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40229](http://purl.obolibrary.org/obo/NCIT_C40229) (Cervical Adenosarcoma))) 38.30%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C40225](http://purl.obolibrary.org/obo/NCIT_C40225) (Cervical Alveolar Soft Part Sarcoma))) 38.30%


